| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/02/2002 | EP1165807A1 A protease, a gene therefor and the use thereof |
| 01/02/2002 | EP1165806A2 Phosphatases with improved phytase activity |
| 01/02/2002 | EP1165805A1 Dsp-2 dual-specificity map kinase phosphatase |
| 01/02/2002 | EP1165804A1 Plant rna-directed rna polymerase proteins |
| 01/02/2002 | EP1165803A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
| 01/02/2002 | EP1165802A1 Genetically modified plants with altered starch |
| 01/02/2002 | EP1165801A1 Linoleate and linolenate-lipoxygenase mutants |
| 01/02/2002 | EP1165800A2 Mitomycin biosynthetic gene cluster |
| 01/02/2002 | EP1165799A1 Microbiological production method for alpha-l-aspartyl-l-phenylalanine |
| 01/02/2002 | EP1165798A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/02/2002 | EP1165797A2 Particles for gene therapy |
| 01/02/2002 | EP1165796A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 01/02/2002 | EP1165795A2 Streptococcus pneumoniae antigens |
| 01/02/2002 | EP1165794A1 Pathogen inducible promoter |
| 01/02/2002 | EP1165793A2 Cyclin dependent kinase inhibitor genes from plants |
| 01/02/2002 | EP1165791A2 Human cytokine as ligand of the zalpha receptor and uses thereof |
| 01/02/2002 | EP1165790A1 Protease activated receptor 2 variants |
| 01/02/2002 | EP1165789A2 Vesicle associated proteins |
| 01/02/2002 | EP1165788A2 Molecules of the immune system |
| 01/02/2002 | EP1165787A2 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 01/02/2002 | EP1165786A1 Polynucleotide synthesis using a processing enzyme |
| 01/02/2002 | EP1165785A1 48 human secreted proteins |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165782A1 Improved methods for recombinant peptide production |
| 01/02/2002 | EP1165781A2 Protease resistant flint analogs |
| 01/02/2002 | EP1165780A2 Flint polypeptide analogs |
| 01/02/2002 | EP1165779A1 A presenilin associated membrane protein and uses thereof |
| 01/02/2002 | EP1165778A2 Casb618 polynucleotides and polypeptides and their use |
| 01/02/2002 | EP1165777A2 Genes encoding human potassium channel proteins |
| 01/02/2002 | EP1165776A1 TYROSINE KINASE RECEPTOR EphA3 ANTIGENIC PEPTIDES |
| 01/02/2002 | EP1165775A2 Recombination of insertion modified nucleic acids |
| 01/02/2002 | EP1165774A2 Casb619 involved in colon cancers |
| 01/02/2002 | EP1165773A1 Advanced antigen presentation platform |
| 01/02/2002 | EP1165772A1 Protein-protein complexes from s. cerevisiae and methods of using same |
| 01/02/2002 | EP1165771A2 Rt-pcr of clonal neurospheres |
| 01/02/2002 | EP1165770A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
| 01/02/2002 | EP1165769A1 Method for fractionating double-stranded nucleic acids in solutions in order to obtain single-stranded nucleic acids |
| 01/02/2002 | EP1165768A1 METHODS OF OBTAINING FULL-LENGTH NUCLEIC ACID SEQUENCES USING $i(E. COLI) TOPOISOMERASE III AND ITS HOMOLOGS |
| 01/02/2002 | EP1165767A1 Dna binding proteins that interact with npr1 |
| 01/02/2002 | EP1165765A2 Arabidopsis thaliana derived frigida gene conferring late flowering |
| 01/02/2002 | EP1165763A1 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 01/02/2002 | EP1165762A2 Alpha-amylase variants |
| 01/02/2002 | EP1165761A2 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
| 01/02/2002 | EP1165760A2 A method for increasing the processivity of a dna- or rna-dependent polymerase and compositions therefor |
| 01/02/2002 | EP1165759A1 Polypeptides having branching enzyme activity and nucleic acids encoding same |
| 01/02/2002 | EP1165758A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules |
| 01/02/2002 | EP1165757A1 Encryption of traits using split gene sequences |
| 01/02/2002 | EP1165755A1 Banana and melon promoters for expression of transgenes in plants |
| 01/02/2002 | EP1165750A1 Diagnosis of whipple disease |
| 01/02/2002 | EP1165617A2 Anti-plasmodium compositions and methods of use |
| 01/02/2002 | EP1165616A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 01/02/2002 | EP1165609A2 Human beta-secretase enzyme, inhibitors and their compositions and uses |
| 01/02/2002 | EP1165607A2 Protein (tp) that is involved in the development of the nervous system |
| 01/02/2002 | EP1165606A1 50 human secreted proteins |
| 01/02/2002 | EP1165605A1 Androgen-induced suppressor of cell proliferation and uses thereof |
| 01/02/2002 | EP1165604A2 Proteins related to neuronal regeneration and uses thereof |
| 01/02/2002 | EP1165603A1 Human neurogenin 3-encoding nucleotide sequences |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165599A1 Purification of biological preparations |
| 01/02/2002 | EP1165598A1 Hookworm platelet inhibitor |
| 01/02/2002 | EP1165594A1 Antisense oligonucleotide modulation of stat3 expression |
| 01/02/2002 | EP1165593A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 01/02/2002 | EP1165592A1 INSECT p53 TUMOR SUPPRESSOR GENES AND PROTEINS |
| 01/02/2002 | EP1165591A1 47 human secreted proteins |
| 01/02/2002 | EP1165590A1 49 human secreted proteins |
| 01/02/2002 | EP1165587A1 50 human secreted proteins |
| 01/02/2002 | EP1165586A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 01/02/2002 | EP1165585A1 Cleavage of nucleic acid from solid supports |
| 01/02/2002 | EP1165579A1 Method for producing endotoxin-free nucleic acids and the use thereof |
| 01/02/2002 | EP1165569A1 Boronic acid containing reagents and oligonucleotides |
| 01/02/2002 | EP1165201A1 Fluidised bed purification of bio-macromolecules such as plasmid dna, chromosomal dna, rna, viral dna, bacteria and viruses |
| 01/02/2002 | EP1165185A2 Human tumor necrosis factor receptor-like 2 |
| 01/02/2002 | EP1165184A2 Estrogen receptor-beta antagonism and bone diseases |
| 01/02/2002 | EP1165145A1 Antisense modulation of mdmx expression |
| 01/02/2002 | EP1165143A2 Method for expressing proteins |
| 01/02/2002 | EP1165135A1 Method of affecting cholesterol catabolism using nucear bile acid receptor |
| 01/02/2002 | EP1165133A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 01/02/2002 | EP1165131A2 Attenuated dengue-1 virus vaccine |
| 01/02/2002 | EP1165130A2 Attenuated dengue-3 virus vaccine |
| 01/02/2002 | EP1165129A1 Attenuated dengue-4 virus vaccine |
| 01/02/2002 | EP1165128A2 Attenuated dengue-2 virus vaccine |
| 01/02/2002 | EP1165124A1 Recombinant neospora antigens and their uses |
| 01/02/2002 | EP1165114A1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 01/02/2002 | EP1165112A1 Modulators of polysaccharides and uses thereof |
| 01/02/2002 | EP1165093A1 Method for validating/invalidating target(s) and pathways |
| 01/02/2002 | EP1165059A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis |
| 01/02/2002 | EP1165047A1 Fusogenic lipids and vesicles |
| 01/02/2002 | EP1005372B1 Anti-cd40l immunotoxins for the treatment of diseases |
| 01/02/2002 | EP1000083A4 Oxidized styrenic polymers for dna binding |
| 01/02/2002 | EP0948652A4 Insect sodium channels from insecticide-susceptible and insecticide-resistant house flies |
| 01/02/2002 | EP0934342B1 Composition containing chitosan |
| 01/02/2002 | EP0877796A4 Compositions and methods for mediating cell cycle progression |
| 01/02/2002 | EP0877549A4 Methods and compositions for the reduction of xenotransplantation rejection |
| 01/02/2002 | EP0851867B1 Universal spacer/energy transfer dyes |
| 01/02/2002 | EP0822829B1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 01/02/2002 | EP0815257B1 A method of detecting biologically active substances |
| 01/02/2002 | EP0815117B1 C-nucleoside derivatives and their use in nucleic acid detection |
| 01/02/2002 | EP0782633A4 Topographic genotyping |
| 01/02/2002 | EP0774014A4 Methods for measuring telomere length |
| 01/02/2002 | CN2469017Y Desk type gas gene gun |